Ferric Carboxymaltose
4
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Ferric Carboxymaltose
Research Leaders
5 sponsors active, led by Xuanwu Hospital, Beijing
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Ferric Carboxymaltose Methemoglobinemia Study
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency
Iron Intravenous Therapy in Reducing the Burden of Severe Arrhythmias in Heart Failure With Reduced Ejection Fraction
Research Network
Common Treatments
- Ferric Carboxymaltose2
- Initial Fcm1
- Ferric Carboxymaltose Fcm1
- Subsequent Exercise Training1
- Initial Exercise Training1
Active Sponsors
- Xuanwu Hospital, Beijing1
- Aristotle University Of Thessaloniki1
- Herzzentrum Bremen1
- Marmara University Pendik Training and Research Hospital1
- Ordu University1
Top Investigators
Marmara University School of Dentistry
Çorlu Vatan Hospital
Bursa City Hospital
Bursa City Hospital
Mehmet Yılmaz Aydınlar Acıbadem University
Related Conditions
- Heart Failure With Reduced Ejection Fraction2
- Arrhythmias Cardiac1
- Methemoglobinemia1
- Parenteral Iron Therapy1
- Anemia Irondeficiency1